ASX Today, page-26837

Never miss an update

Get the latest insights from me in your inbox when they’re published.

FOLLOW

Growth Prospects

When MarketMeter talks about the Growth Prospects of companies, as one of 27 factors considered across five broader category definitions, it’s referring to the growth of:

• Earnings per share (EPS) and share price,
• Market share, and
• Position within current and future addressable markets.

In this series, we’ve selected six MarketMeter factors that we think Livewire readers will be most interested to learn more about. My colleague Chris Conway kicked off this series with Sustainability Reporting, which falls under the ESG category group. And Hans Lee followed up with his wire on the Investment Desirability metric, part of the Financial Category.

Top 10 ASX 100 companies in terms of Growth Prospects

These are the ASX 100 companies that fund managers scored highest with regard to the prospective further growth in their earnings per share, market share, and overall market positioning. The list appears in order based on the results of the most recent MarketMeter research.

1. Macquarie Group (ASX: MQG)
2. CSL Limited (ASX: CSL)
3. Fisher & Paykel Healthcare (ASX: FPH)
4. Xero (ASX: XRO)
5. Lendlease Group (ASX: LLC)
6. Aristocrat Leisure Limited (ASX: ALL)
7. Transurban Group (ASX: TCL)
8. ResMed (ASX: RMD)
9. Goodman Group (ASX: GMG)
10. ALS Limited (ASX: ALQ)

Top 10 ASX 101-200 companies in terms of Growth Prospects

These are the ASX 101-200 companies that fund managers scored highest with regard to the prospective further growth in their earnings per share, market share, and overall market positioning. The list appears in order based on the results of the most recent MarketMeter research.

1. Chalice Mining (ASX: CHN)
2. Liontown Resources (ASX: LTR)
3. Lovisa Holdings (ASX: LOV)
4. Bapcor Limited (ASX: BAP)
5. Arena REIT (ASX: ARF)
6. Domain Holdings Australia (ASX: DHG)
7. Corporate Travel Management (ASX: CTD)
8. HUB24 Limited (ASX: HUB)
9. Brainchip Holdings (ASX: BRN)
10. Telix Pharmaceuticals (ASX: TLX).

Livewire seems to think there's a future for LTR.
Cheers Suzee